SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
IN PARTNERSHIP WITH IQVIA
How Target Product Profiles Guide the Industry Through Uncertain Times
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the importance of target product profiles, particularly when navigating funding challenges, with Ian Fisher, head of development analytics.
May 22, 2025
 · 
1 min read
 · 
Lori Ellis
Hand touching virtual checklist with a checkmark, symbolizing approval, against backdrop of automated pharmaceutical production line
Job Trends
11 Companies Hiring Manufacturing Professionals
Looking for a manufacturing job? Check out the BioSpace list of 11 companies hiring life sciences professionals like you.
May 22, 2025
 · 
2 min read
 · 
Angela Gabriel
Aerial view of Raleigh, North Carolina skyline on a sunny day
Business
Southeast’s Life Sciences Scene Heats Up With Job, Business Growth
Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 data from BIO and TEConomy Partners. NCBiotech and Bexion executives discuss the area and the pros and cons of setting up shop far from major hubs.
May 22, 2025
 · 
6 min read
 · 
Angela Gabriel
Canada US crisis concept as a Broken Rope stretched with force and stressed to a decoupling metaphor for pressure on the economic and political relationship between Ottawa and Washington.
Drug pricing
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
Canada’s health agency says it has been “taking all necessary action safeguard the drug supply and ensure Canadians have access to the prescription drugs they need.”
May 22, 2025
 · 
2 min read
 · 
Annalee Armstrong
New York City, NY, USA - August 22, 2022: Pfizer world headquarters in New York City, USA. Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation.
Adcomms
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
The FDA’s independent advisors found Pfizer’s data lacked the precision needed to establish the efficacy of Talzenna in patients with prostate cancer who do not carry HRR mutations.
May 22, 2025
 · 
2 min read
 · 
Tristan Manalac
The COVID-19 vaccine in glass bottles for prevention, immunization, and treatment of coronavirus infection on a green background. Space for text. Concept of medical and vaccine.
Vaccines
FDA Asks Pfizer/BioNTech, Moderna To Add Myocarditis Risk to COVID-19 Vaccines
The FDA had given Pfizer and Moderna until May 17 to propose changes to the labels of their COVID-19 vaccines or challenge the agency’s directive. The products’ labels already include myocarditis warnings, albeit for different age groups.
May 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Eli Lilly's biotechnology center in California
Drug pricing
‘We Don’t Believe This Is Right’: Lilly Bristles as CMS Leaves Obesity Drugs Out of Medicare
The CMS last month declined to include anti-obesity medications in its Medicare coverage for Part D, a move that Lilly says could interfere with patients getting the appropriate medical care.
May 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Neurology, philosophy: connections, the development of thought and reflection, the infinite possibilities of the brain and mind. Creativity stock photo
Mergers & acquisitions
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target
The deal helps revitalize the TREM2 target after the high-profile failure of AbbVie and Alector’s candidate last year.
May 22, 2025
 · 
4 min read
 · 
Annalee Armstrong
Cambridge, USA - 16 August 2024. View of Moderna office entrance with logo sign, Biotechnology industry
Vaccines
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy in eliciting antibodies in data announced earlier this month.
May 21, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS